Accuray Incorporated (ARAY) vs MDxHealth S.A. (MDXH)
A side-by-side comparison of Accuray Incorporated and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARAY
Accuray Incorporated
$0.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MDXH
MDxHealth S.A.
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ARAY vs MDXH
growth of $100 · dividends reinvested · last 5yARAY -94.4% (-43.8%/yr)MDXH -95.0% (-45.1%/yr)ARAY compounded faster over this window
ARAY MDXH
ARAY vs MDXH: by the numbers
- •ARAY is the larger company ($31M vs $31M market cap).
- •Both run net losses; ARAY's is the smaller (-12.24% vs -31.07% net margin).
- •MDXH grew revenue faster over the past five years (42.35% vs 0.28% CAGR).
Metrics side by side
Valuation
| Metric | ARAY | MDXH |
|---|---|---|
| P/S ratio | 0.08 | N/A |
| P/B ratio | 0.75 | N/A |
Profitability
| Metric | ARAY | MDXH |
|---|---|---|
| Gross margin | 27.73% | 59.74% |
| Operating margin | -6.58% | -14.28% |
| Net margin | -12.24% | -31.07% |
| ROE | -117.97% | N/A |
| ROIC | -10.09% | -15.35% |
Growth (annualized)
| Metric | ARAY | MDXH |
|---|---|---|
| Revenue CAGR (5Y) | 0.28% | 42.35% |
| Total return CAGR (5Y) | -39.94% | N/A |
Frequently asked
- Which has grown faster, ARAY or MDXH?
- Over the past five years, MDXH grew revenue faster — ARAY at a 0.28% CAGR versus MDXH at 42.35%.
Go deeper
Dig into the metrics
Accuray ROEMDxHealth ROEAccuray operating marginMDxHealth operating marginAccuray revenue growthMDxHealth revenue growthAccuray free cash flowMDxHealth free cash flow
Accuray & MDxHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.